Insider Trading News: Skyworks Solutions Inc (SWKS), Palo Alto Networks Inc (PANW), Celldex Therapeutics, Inc. (CLDX), Rockwell Medical Inc (RMTI)


Recently, various executives have taken part in insider trading activity for the stocks of Skyworks Solutions Inc (NASDAQ:SWKS), Palo Alto Networks Inc (NYSE:PANW), Celldex Therapeutics, Inc. (NASDAQ:CLDX), and Rockwell Medical Inc (NASDAQ:RMTI).

Skyworks Solutions Inc

CEO David Aldrich unloaded 10,000 Skyworks Solutions shares (6.25% of total stake), valued at $903,000, in a transaction dated August 11. The shares were sold via automatic sale program. Aldrich now holds directly and indirectly 150,091 of the company’s shares that are valued at $13,553,217.

EVP of Worldwide Operations Bruce Freyman sold 8,000 shares (19.62% of total stake), valued at $720,000, on August 10. The shares were sold via automatic sale program. Freyman now holds 32,776 of the company’s shares that are valued at $2,918,375.

Click Here to see the performance of Skyworks Solutions insiders.

Palo Alto Networks Inc

President and CEO Mark Mclaughlin unloaded 25,000 Palo Alto Networks shares (3.58% of total stake), valued at $4,359,415, in multiple transactions dated August 11. The shares were sold via automatic sale program. Mclaughlin now holds 698,789 of the company’s shares that are valued at $120,023,999.

CTO Nir Zuk disposed of 30,000 shares (1.38% of total stake), valued at $5,195,162, in six transactions on August 7. The shares were sold via automatic sale program. Zuk now holds 2,149,673 of the company’s shares that are valued at $369,227,834.

Click Here to see the performance of Palo Alto Networks insiders.

Celldex Therapeutics, Inc.

President and Ceo Anthony Marucci bought 5,800 Celldex shares worth $97,440 at an average price of $16.80, as reported in the SEC filing yesterday. Following the insider-buying transaction, his stake in Celldex has now grown to 50,028 shares with a value of $838,970.

Director Larry Ellberger purchased yesterday 5,000 shares, valued at $82,950. After completion of the transaction, Ellberger owns 38,500 shares, worth $645,645.

Click Here to see the performance of Celldex Therapeutics insiders.

Rockwell Medical Inc

Chairman, President and CEO Robert Chioini yesterday purchased 5,090 Rockwell shares, valued at $58,597. After completion of the transaction, Chioini owns 1,789,023 shares, worth $20,627,435.

Chief Scientific Ajay Gupta bought yesterday 5,000 shares worth $58,112 at an average price of $11.62. Following the insider-buying transaction, his stake in Rockwell has now grown to 326,667 shares with a value of $3,766,471.

Click Here to see the performance of Rockwell Medical insiders.